Clinical Topics & News

Call for Articles on Hematology/Oncology

Submit a proposal to share your research, best practices, or case study for the upcoming Federal Practitioner/AVAHO special issues.


 

Federal Practitioner articles are now available in PubMed Central, which provides full text access to any reader and is included in all PubMed online searches.

Federal Practitioner is inviting VA, DoD, and PHS health care providers and researchers to contribute to the May 2018 and August 2018 Advances in Hematology and Oncology special issues. The special issues are produced in cooperation with the Association of VA Hematology/Oncology (AVAHO). The journal is especially interested in articles on lung, prostate, and head and neck cancers; melanoma and skin cancers; survivorship; patient navigation; lymphomas; leukemias; multiple myeloma; neuroendocrine tumors; and immunotherapies.

Interested authors can send a brief 2 to 3 sentence abstract to fedprac@frontlinemedcom.com by March 15, 2018, or submit a completed article directly into Editorial Manager, a web-based manuscript submission and review system. Federal Practitioner welcomes case studies, literature reviews, original research, program profiles, guest editorials, and other evidence-based articles. The updated and complete submission guidelines, including details about the style and format, can be found here:

http://www.mdedge.com/fedprac/page/submission-guidelines

All manuscripts submitted to Federal Practitioner for both special and regular issues will be subject to peer review. Peer reviews are conducted in a double-blind fashion, and the reviewers are asked to comment on the manuscript’s importance, accuracy, relevance, clarity, timeliness, balance, and reference citation. Final decisions on all submitted manuscripts are made by the Editorial Advisory Association Hematology/Oncology special issue advisory board.

Recommended Reading

The Challenges of Precision Medicine and New Advances in Molecular Diagnostic Testing in Hematolymphoid Malignancies: Impact on the VHA (FULL)
Federal Practitioner
FDA approves first gene therapy – tisagenlecleucel for ALL
Federal Practitioner
Recurrent Cisplatin Hypersensitivity Reaction After First Exposure: A Case Report
Federal Practitioner
Electronic Consultation: An Efficient and Effective Way to Manage Hematology Consults
Federal Practitioner
Abstracts Presented at the 2017 AVAHO Annual Meeting (Digital Edition)
Federal Practitioner
FDA Approves Treatment for Chronic GVHD
Federal Practitioner
State regulations for tattoo facilities increased blood donor pools
Federal Practitioner
Treatment and Management of Multiple Myeloma (FULL)
Federal Practitioner
Can Albumin/Globulin Levels Predict Digestive Cancer Prognosis?
Federal Practitioner
Treating Cancer Fatigue With Placebo
Federal Practitioner